Perioperative management of the patient with respiratory disease
Click here to load reader
-
Upload
janis-shaw -
Category
Documents
-
view
224 -
download
0
Transcript of Perioperative management of the patient with respiratory disease
![Page 1: Perioperative management of the patient with respiratory disease](https://reader038.fdocuments.in/reader038/viewer/2022100422/575074091a28abdd2e92740e/html5/thumbnails/1.jpg)
PERIOPERATIVE MANAGEMENT OF CO-MORBID CONDITIONS
Perioperative management ofthe patient with respiratorydiseaseJanis Shaw
Analysis of co-existing medical problems in one sampleof 1911 patients who died within 3 days followingemergency surgery
Co-existing medical problems at the time
of final operation (answers may be multiple)
Frequency (%)
None/question not answered 4
Cardiovascular 76
Respiratory 56
Neurological 37
Alimentary 25
Renal 21
Sepsis 20
Endocrine 17
Musculoskeletal 13
AbstractCardiorespiratory disease is the commonest cause of perioperative
morbidity and mortality in the western world. Each year in the UK, around
25,000 to 30,000 patients die within 30 days of surgery. The most impor-
tant pulmonary complications are exacerbation of existing respiratory
disease, pneumonia and respiratory failure. The key to reducing problems
in this group of patients is identification of those individuals most at risk
and optimization of medical management. A perioperative care plan can
then be instituted for each individual patient in order to gain maximum
benefit from available therapeutic interventions. While complications can
never be totally prevented, a worsening of vital signs generally precedes
impending critical illness. Prompt recognition of any physiological deteri-
oration and early intervention are the key to avoiding a poor outcome in
such circumstances. Early warning scoring (EWS) systems have been
implemented in many postoperative care areas to draw attention to any
deterioration in vital signs at an early stage. This article focuses on the
perioperative management of patients with respiratory disease.
Keywords Cardiopulmonary exercise test; early warning score; peri-
operative risk; postoperative lung function; postoperative respiratory
failure; pulmonary function tests
Overall strategy and general assessment
Of the 25,000 to 30,000 patients who die within 30 days of
surgery in the UK per annum, the majority are >65 years old and
are suffering from one or more co-existing medical disorders at
the time of operation. Data from the National Confidential
Enquiry into Perioperative Deaths (NCEPOD)1 shown in Table 1
give a detailed analysis according to the prevalence of co-existing
medical problems of one sample of 1911 patients who died
within 3 days of surgery. Respiratory disease ranks only second
to cardiovascular disease as a contributory comorbidity.
A detailed history and physical examination, together with the
sensible application of preoperative screening tests should
identify those patients who fall into a higher risk category. The
surgical team should aim to:
� make an initial assessment of the severity of the respiratory
disease process
� assess the patient’s functional capacity
� ensure optimal medical management of the underlying
disease and treat any current chest infection
Janis Shaw FRCA is a Consultant Cardiothoracic Anaesthetist at
Manchester Royal Infirmary, Manchester, UK and Honorary Lecturer at
the University of Manchester. Conflicts of interest: none declared.
SURGERY 28:9 427
Any patient deemed to fall into a higher than normal risk cate-
gory should be referred, either directly for an anaesthetic
opinion, or via a respiratory physician if it appears that the
patient’s respiratory status could be improved. This strategy
should avoid the ‘last-minute’ cancellation of an elective proce-
dure. In an emergency situation, options for improving patient
status are limited but a rapid referral for an emergency consul-
tation and effective multidisciplinary team working can often
improve outcomes.
Risk factors associated with postoperative pulmonary
complications
A recent systematic literature review2 identified a number of
factors associated with increase likelihood of postoperative
pulmonary complications and these are dependent on:
� patient-related risk factors
� procedure-related risk factors
Patient-related risk factors
Age: unadjusted risk attributable to increasing age was previ-
ously believed to be due to the accumulation of comorbid
conditions, but evidence now shows that advancing age is an
important independent predictor of postoperative pulmonary
complications. NCEPOD data shows that the risk rises sharply
over the age of 65. Patients aged 70 or over have an approxi-
mately four times greater risk of developing postoperative
pulmonary complications.
Respiratory disease status: patients with respiratory disease
frequently develop pulmonary complications following surgery.
A functional classification of some of the problems associated
with chronic pulmonary disease is shown in Table 2. Meta-
analysis has shown that chronic obstructive pulmonary disease
(COPD) is the most frequently identified risk factor and is more
likely to be associated with postoperative respiratory failure than
either chronic restrictive pulmonary disease or other restrictive
pathologies.
Haematological 11
Hepatic 6
Other 11
Table 1
� 2010 Elsevier Ltd. All rights reserved.
![Page 2: Perioperative management of the patient with respiratory disease](https://reader038.fdocuments.in/reader038/viewer/2022100422/575074091a28abdd2e92740e/html5/thumbnails/2.jpg)
Functional classification of respiratory disorders
Functional change Disease process
Air trapping and
bronchospasm
C Asthma
C Emphysema
Excessive pulmonary
secretions
C Chronic bronchitis
C Intercurrent chest infection
C Bronchiectasis
C Pulmonary oedema
Parenchymal lung disease
Showing a
restrictive pattern
C Idiopathic fibrotic disease
C Connective tissue disorders
C Sarcoidosis and primary lung disease
C Drug-induced lung disease
Extraparenchymal disease
Showing a
restrictive pattern
C Chest wall abnormalities
C Pleural disease
C Neuromuscular disorders
Reduced ventilatory
capacity
C Central nervous system depression
C Diaphragmatic paralysis
C Obstructive sleep apnoea
Table 2
PERIOPERATIVE MANAGEMENT OF CO-MORBID CONDITIONS
Other comorbidities: The American Society of Anesthesiologists’
(ASA) Classification, which predicts perioperative mortality, has
been shown to predict both pulmonary and cardiac postoperative
complications. Patients in ASA classes IIeV have a fourfold
greater risk of developing postoperative pulmonary complica-
tions. There is particularly good evidence to support identifica-
tion and treatment of any element of congestive cardiac failure as
this is independently associated with an increased risk of
pulmonary complications.
Smoking history: there is a modest increase in the risk of
postoperative pulmonary complications in ex-smokers, whereas
current smokers have an approximately fivefold greater risk. In
order to reduce this risk, patients need to stop smoking 8 weeks
prior to surgery. Curiously, patients who stop smoking less than
8 weeks before surgery may have a slightly increased risk. There
may be some benefit in abstaining from smoking for 12 hours
prior to surgery as this will reduce the level of carbox-
yhaemoglobin and improve oxygen-carrying capacity.
Functional dependence: functional dependence has been
shown to be a risk factor for postoperative pulmonary compli-
cations. Total functional dependence is the inability to perform
any activities of daily living and carries a threefold increase in
risk. Partial dependence is the need for equipment or devices
and assistance from another person for some activities of daily
living and carries a 1.5 times increase in risk.
Procedure-related risk factors
These include surgical factors such as the site of the surgery, the
duration of surgery, anaesthetic technique and emergency
surgery. The major procedure-related risk factors have been
shown to confer a higher risk for pulmonary complications than
the patient-related risk factors.
SURGERY 28:9 428
Surgical site: patients undergoing open aortic surgery are at the
greatest risk for postoperative pulmonary complications e
a sevenfold increase in incidence. Other high-risk surgeries
include thoracic and upper abdominal procedures, which carry
a three- to fourfold increase in risk, respectively.
Duration of surgery: prolonged surgery approximately doubles
the risk of developing postoperative pulmonary complications.
The definition of prolonged surgery varied between 2.5 and
4 hours in published studies.
Anaesthetic technique: the administration of general anaes-
thesia doubles the risk of developing postoperative pulmonary
complications compared with the use of regional or local
anaesthetic techniques.
Emergency surgery: again the risk of postoperative pulmonary
complications is doubled when the surgery needs to be per-
formed as an emergency rather than as an elective procedure.
Preoperative assessment and risk stratification
A detailed history and examination should be performed to
identify all known potential risk factors and to evaluate the
patient’s pre-existing pulmonary status.
Respiratory disease status
Any element of airway obstruction should be well controlled prior
to elective surgery. Detailed recommendations for the manage-
ment of asthmatic patients have recently been published jointly by
the British Thoracic Society and the Scottish Intercollegiate
Guidelines Network (SIGN).3 Inhaled b2 agonists (e.g. salbuta-
mol), inhaled steroids (e.g. beclomethasone) and antimuscarinic
drugs (e.g. ipratropium) are themainstays of treatment and should
always be continued perioperatively. Current or recent treatment
with systemic steroids invariably indicates greater severity of
disease or a recent exacerbation. Any patient taking 10mg ormore
of prednisolone daily will require perioperative hydrocortisone
supplementation. If active pulmonary infection is suspected the
patient’s sputum should be obtained for laboratory culture and
sensitivity and a course of appropriate antibiotics should be
prescribed once sensitivities are known. Referral to a chest
physician may be indicated if the history suggests that respiratory
status may be improved by further optimization of therapy. Some
patients who have very poor control may benefit from a week’s
course of systemic steroids in the perioperative period.
Further investigations to estimate risk
Routine investigations for patients with respiratory disease
generally include blood tests, chest X-ray and pulmonary func-
tion testing.
Blood tests: full blood count, urea and electrolytes and liver
function tests should be performed as a routine. A small number
of studies have identified raised serum levels of urea and
creatinine as independent risk factors. Hypoalbuminaemia (<36
g/litre) has been shown to be a very important predictor of
30-day perioperative morbidity and mortality.
Chest X-ray: most studies of the value of preoperative chest
X-rays have evaluated the impact of abnormal findings on
� 2010 Elsevier Ltd. All rights reserved.
![Page 3: Perioperative management of the patient with respiratory disease](https://reader038.fdocuments.in/reader038/viewer/2022100422/575074091a28abdd2e92740e/html5/thumbnails/3.jpg)
A comparison of pulmonary function test results inrestrictive and obstructive disease (FVC, forced vitalcapacity; FEV1, forced expiratory volume in 1 s)
Measurement Restrictive disease Obstructive disease
FVC Decreased Normal or decreased
FEV1 Decreased Normal or decreased
FVC/FEV1 Normal Decreased
Table 3
PERIOPERATIVE MANAGEMENT OF CO-MORBID CONDITIONS
perioperative management rather than postoperative pulmonary
complications. In a series of eight studies, 23.1% of preoperative
chest radiographs showed an abnormality but only 3% influ-
enced management.
Pulmonary function tests: an understanding of the normal
physiological lung volumes, shown in Figure 1, is essential when
interpreting many of the routinely performed preoperative
pulmonary function tests.
Spirometry: forced vital capacity (FVC) and forced expiratory
volume in 1 second (FEV1) are the most common pulmonary
function tests performed as part of routine preoperative assess-
ment. The patient performs a maximum inspiration to total lung
capacity and then breathes out as quickly as possible to maximum
expiration. The FVC and FEV1,which are typicallymeasured using
a Vitalograph or a mobile device, may be used to assess the nature
and severity of respiratory disease (see Table 3). The FEV1/FVC
ratio is normal (over 70%) in restrictive lung disease but reduced
in obstructive lung disease. If the patient has an obstructive
pattern, measurements should be repeated 5e10 minutes after
administration of an inhaled bronchodilator to assess acute
reversibility. The tests are very dependent on patient effort and can
be unreliable. In terms of risk stratification, it has been shown that
most patients identified as high risk by spirometry canbe identified
equally well by clinical evaluation. The FEV1 has been validated as
the most useful single measure for predicting poor outcome. An
FEV1< 0.8 l and an FVC< 1 l indicate that the patient’s cough will
be poor and respiratory support is likely to be required following
major surgery.
Peak expiratory flow rate: measurement of peak expiratory
flow rate (PEFR) can be performed at the bedside with a peak
flow meter. PEFR falls during obstructive episodes and is useful
for monitoring the response to bronchodilator therapy. Coughing
is ineffective when PEFR < 200 litres/minute.
Physiological lung volumes (litres). Normal tidalventilation and one large vital capacity breathare shown
Ph
ysio
log
ica
l lu
ng
vo
lum
es
(lit
res)
5.0
3.0
2.5
1.25
0
Residual volume
Total
lung
capacity
Vital
capacity
Inspiratory
capacity
Expiratory
reserve
volume
Tidal
volume
Functional
residual
capacity
Inspiratory
reserve
volume
Figure 1
SURGERY 28:9 429
Diffusing capacity for carbon monoxide: parenchymal
(alveolar-capillary membrane) lung function is typically assessed
by measuring the diffusing capacity for carbon monoxide
(DLCO). Patients requiring more than simple spirometry (i.e.
DLCO, arterial blood gas analysis) should be assessed using
a multidisciplinary approach.
Assessment of functional capacity
Cardiorespiratory reserve should be expressed in Metabolic
Equivalents of Task (MET). Patients should be able to perform
four METs (equivalent to climbing a flight of stairs) of physical
activity or more if they are to be considered for major surgery.
Patients’ estimations of their exercise capability are very
subjective and may frequently be overestimated.
Cardiopulmonary exercise testing (CPET) is regarded as
a very reliable, objective test of functional capacity.4 It has now
been recognized as an acceptable method of quantifying
a patient’s ability to respond to the increased metabolic demands
of major surgery.5 CPET is currently available in more that 30
centres across the UK and provides a safe, non-invasive,
repeatable, individual assessment of combined pulmonary,
cardiac and circulatory function. If CPET is not available, simple
walk tests such as the 6-minute walk test (6MWT) provide an
acceptable alternative measure of global cardiorespiratory func-
tion. The 6MWT measures how far a patient can walk along a flat
corridor turning around cones at each end. A median distance
attained is around 500e600 m in healthy subjects.
Perioperative care
A perioperative care plan should be produced for each patient.
All patients having major surgery and identified as falling into
a high-risk category for postoperative pulmonary complications
should be cared for in an appropriately staffed high-dependency
(level 2) or intensive therapy unit (level 3) facility. In ideal
circumstances, all patients suffering from significant respiratory
problems would go to a high-care area following surgery.
Unfortunately, the lack of resources often dictates that patients
may need to return to a ward environment. The difficult decision
of where to send the patient in the immediate postoperative
period should be undertaken by the multidisciplinary team.
Factors affecting complication rates
There are many reasons why patients with pre-existing pulmo-
nary disease develop complications. The most important respi-
ratory problems in this group of patients are exacerbation of
existing respiratory disease, pneumonia and respiratory failure.
There is a complex relationship between all the factors involved
in the development of postoperative respiratory failure
� 2010 Elsevier Ltd. All rights reserved.
![Page 4: Perioperative management of the patient with respiratory disease](https://reader038.fdocuments.in/reader038/viewer/2022100422/575074091a28abdd2e92740e/html5/thumbnails/4.jpg)
PERIOPERATIVE MANAGEMENT OF CO-MORBID CONDITIONS
(Figure 2). This section identifies the risk factors which have not
yet been considered and discusses some of the pathophysiology
involved in the development of postoperative respiratory failure.
Metabolic response to surgery: the inflammatory response
provoked by major surgery increases the body’s oxygen
consumption by up to 40% or more. This state of increased
oxygen demand, which persists for several days is largely met by
an increase in cardiac output. Any disease which affects the
function of the cardiac or respiratory systems may mean the
patient is unable to increase oxygen delivery to meet these
increased metabolic demands.
Effects of anaesthesia: significant atelectasis occurs within
minutes of the induction of general anaesthesia. General anaes-
thesia reduces functional residual capacity (FRC) of the lungs by
as much as 20%. Collapse of the airspaces occurs as the FRC falls
below the lung’s closing capacity (CC). The CC is the lung
volume at which the small dependent airways collapse causing
basal (dependent) alveolar atelectasis and ventilation/perfusion
mismatch leading to hypoxaemia. Decreased FRC is associated
with increasing age, obesity and the supine position. If possible,
general anaesthesia should be avoided in patients with severe
respiratory disease. Local or regional anaesthetic techniques are
preferable. For peripheral operations, spontaneously breathing
techniques may lead to less postoperative morbidity and are
Factors which affect the development of postoperative respir
Atelecta↓ Ventilation
and impaired cough
Oxygen thand hype
Effects of chroniclung disease
Effect of postoperativeopioids
↑ Mucus seChest wall & respiratory
muscle functionNeurological
Effects of anaand surg
Figure 2
SURGERY 28:9 430
often well tolerated. If surgery cannot be undertaken without
muscle relaxation a short-acting neuromuscular blocking drug
should be administered as part of the anaesthetic technique.
Some anaesthetists use a combined general/epidural anaesthetic
technique for thoracic major abdominal surgery in the hope of
reducing the risk of complications.
Postoperative hypoventilation: anaesthetic drugs may have
residual effects leading to decreased central respiratory drive and
respiratory muscle weakness. The FRC may be further reduced
by incisional pain and diaphragmatic dysfunction, particularly
after upper abdominal and thoracic procedures. Inadequate
analgesia may impair the ability to cough and clear secretions.
Effective postoperative analgesia is essential but a drug-induced
reduction in central respiratory drive is often associated with the
administration of potent opioids. The used of a regional anaes-
thetic technique (i.e. an epidural) is often effective in allowing
deep breathing, coughing and early mobilization.
Other intraoperative factors: administration of crystalloids,
postoperative fluid retention secondary to vasopressin and
aldosterone and hypoproteinaemia may predispose patients with
impaired left ventricular function to pulmonary oedema, which
increases the alveolarearterial oxygen gradient and reduces lung
compliance. Other factors that may increase alveolar-capillary
permeability include:
atory complications and respiratory failure
sis
↓ Gas exchange
erapy roxia
Postoperative respiratory
failure
Alveolar-capillary membrane
function & oedema
Metabolic response to surgery
cretion Airway
esthesia ery
� 2010 Elsevier Ltd. All rights reserved.
![Page 5: Perioperative management of the patient with respiratory disease](https://reader038.fdocuments.in/reader038/viewer/2022100422/575074091a28abdd2e92740e/html5/thumbnails/5.jpg)
PERIOPERATIVE MANAGEMENT OF CO-MORBID CONDITIONS
� sepsis
� shock
� transfusion of blood and blood products
� high volume mechanical ventilation
� aspiration of gastric contents
Many anaesthetic and surgical procedures are associated with an
increased risk of aspiration of gastric contents leading to bron-
chospasm, airway obstruction, pneumonia or acute lung injury.
Selective use of nasogastric tube drainage after abdominal
surgery may help to prevent postoperative respiratory
complications.
Strategies to reduce complications
A recent systematic review of the literature on interventions to
prevent postoperative pulmonary complications6 is summarized
below:
Strategies of proven benefit: good evidence suggests that lung
expansion therapy reduces postoperative pulmonary risk after
abdominal surgery. Examples of lung expansion therapy include:
� incentive spirometry
� deep breathing exercises
� continuous positive airway pressure (CPAP)
All reduce postoperative pulmonary risk after abdominal
surgery.
Strategies of probable benefit: two strategies of probable benefit
are:
� selective use of nasogastric tube decompression following
abdominal surgery
� use of short-acting neuromuscular blocking agents if muscle
relaxation is required
Strategies of possible benefit: possible benefit may be gained
from the use of:
� laparoscopic procedures compared with open abdominal
operations to reduce pain and pulmonary compromise as
measured by spirometry and oxygenation
� regional anaesthetic techniques such as a continuous epidural
for postoperative pain relief
Strategies of unproven benefit: evidence is insufficient to judge
the potential benefit of:
� preoperative smoking cessation
� the use intraoperative epidural anaesthesia
Early warning score sheet
Observations Score
3 2 1 0
Temperature (�C) �35.0 35.1e36.0 36.1e37.9
Systolic blood
pressure (mmHg)
�70 71e80 81e100 101e199
Heart rate �40 41e50 51e100
Respiratory rate �8 9e14
Central nervous system New confusion Alert
Table 4
SURGERY 28:9 431
More good-quality efficacy trials of sufficient size are needed to
accurately examine complication rates.
Strategies of no benefit: no benefit can be demonstrated
from:
� routine parenteral or enteral hyperalimentation, despite the
fact that malnutrition is associated with increased risk for
postoperative pulmonary complications
� routine perioperative monitoring using a pulmonary artery
flotation catheter
Summary of important strategies to reduce pulmonary
complications
Careful preoperative assessment using a multidisciplinary
approach together with early optimization of medical
management is the key to reducing potential problems. Phys-
ical therapies that aim to improve lung expansion and sputum
clearance, combined with early mobilization, seem to be
crucial in avoiding postoperative respiratory failure. All high-
risk patients with respiratory disease presenting for elective
surgery should have a preoperative consultation with a phys-
iotherapist to learn appropriate techniques which will maxi-
mize postoperative care. Effective postoperative analgesia is
essential to deep breathing, coughing and clearance of secre-
tions, and early mobilization. Postoperative oxygen therapy
should be administered for several days until the patient has
recovered from the metabolic demands imposed by major
surgery.
Recognition of postoperative pulmonary complications
Complications can never be entirely prevented. Every year
large numbers of patients suffer unnecessary morbidity and
mortality because the early signs of catastrophic deterioration
were not noticed. In response, most centres have adopted the
use of early warning scoring (EWS) systems. The EWS relies
on observations of the patient’s physiological status that
reflect the clinical evaluation of oxygen delivery and organ
perfusion. This ensures small deviations in vital signs are
noticed rather than waiting for a more obvious change in
a single variable. Table 4 shows a typical modified EWS
record. It must be remembered that the EWS is a tool and is
only as good as the staff using it. Multidisciplinary interven-
tion is required when an abnormal trend has been recognized.
The team need to familiarize themselves, not just with the
1 2 3
38.0e38.9 �39.0
�200
101e110 111e129 �130
15e20 21e29 �30
Responds to verbal commands Responds to pain No response
� 2010 Elsevier Ltd. All rights reserved.
![Page 6: Perioperative management of the patient with respiratory disease](https://reader038.fdocuments.in/reader038/viewer/2022100422/575074091a28abdd2e92740e/html5/thumbnails/6.jpg)
PERIOPERATIVE MANAGEMENT OF CO-MORBID CONDITIONS
local scoring system, but also with local critical care outreach
services which are in place to manage patients who are
deteriorating. A
REFERENCES
1 Functioning as a Team? The 2002 report of the national confi-
dential enquiry into perioperative deaths, www.ncepod.org.uk/
2002fat.htm.
2 Smetana GW, Lawrence VA, Cornell JE. Preoperative pulmonary risk
stratification for noncardiothoracic surgery: systematic review for
the American College of Physicians. Ann Intern Med 2006; 144:
581e95.
SURGERY 28:9 432
3 British Thoracic Society, Scottish Intercollegiate Guidelines Network.
British guideline on the management of asthma. A national clinical
guideline, www.brit-thoracic.org.uk/clinicalInformation/asthma/
asthmaguidelines/tabid/83/default.aspx; 2008 (revised 2009).
4 Agnew N. Preoperative cardiopulmonary exercise testing. Contin Educ
Crit Care Pain 2010; 10: 33e7.
5 Carlisle J, Swart M. Mid-term survival after abdominal aortic aneurysm
surgery predicted by cardiopulmonary exercise testing. Br J Surg 2007;
94: 966e9.
6 Lawrence VA, Cornell JE, Smetana GW. Strategies to reduce post-
operative pulmonary complications after noncardiothoracic surgery:
systematic review for the American College of Physicians. Ann Intern
Med 2006; 144: 596e608.
� 2010 Elsevier Ltd. All rights reserved.